ClinicalTrials.Veeva

Menu
F

Florida Urology Partners, LLP | Tampa, FL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Relugolix
Enzalutamide
177Lu-
Vibegron
Prednisone
Leuprolide Acetate
Abiraterone

Parent organization

This site is a part of Florida Urology Partners, LLP

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 5 total trials

177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate Cancer

A Multi-Center, Open-Label, Randomized Phase 3 Trial Comparing the Safety and Efficacy of 177Lu-PSMA-I\&T versus Hormone Therapy in Patients with Met...

Active, not recruiting
Metastasis From Malignant Tumor of Prostate
Drug: 177Lu-PSMA-I&T
Drug: Abiraterone with Prednisone or Enzalutamide

The purpose of the ProVIDE II Bridging Study is to evaluate the performance of the Generation II delivery system when deploying the ProVee expander i...

Active, not recruiting
BPH With Symptomatic Lower Urinary Tract Symptoms
Device: ProVee device

This was a randomized study to evaluate the risk of major adverse cardiovascular events (MACE) for relugolix compared with leuprolide acetate. Enroll...

Active, not recruiting
Prostate Cancer
Drug: Leuprolide Acetate
Drug: Relugolix

Trial sponsors

Sumitomo Pharma logo
C
P
U

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems